1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Key Pharma News 30 MARCH 2015

Key Pharma News 30 MARCH 2015

  • March 2015
  • -
  • Espicom Business Intelligence
  • -
  • 28 pages

Industry Trend Analysis - Allergan Acquisition Will Put Actavis Head-To-Head With Teva
Industry Trend Analysis - Kura Will Succeed With Tipifarnib Where J&J Failed
Industry Brief - AbbVie/C2N Enter Worldwide Licence Agreement For AD Therapy
Industry Trend Analysis - Lilly Can Use Local Biotech To Grow Presence In China
Industry Trend Analysis - Takeda's Success In ADCs Relies On Multiple Agreements
Industry Trend Analysis - Successful Diversification Will Help Newly Named Biogen Sustain Growth
Industry Trend Analysis - AstraZeneca Preparing Well To Stave Off Potential Further Takeover Bids
Industry Trend Analysis - Ruthigen Reverse Merger To Boost Pulmatrix' Respiratory Product Development
Industry Trend Analysis - Sale Of Zohydro ER Business Will Raise Capital And Reduce Costs For Zogenix
Industry Trend Analysis - GSK Asset Divestment Highlights Aspen's Success
Industry Brief - Endo Withdraws Proposal To Acquire Salix
Industry Brief - Janssen Acquires XO1
Industry Trend Analysis - Sun/Ranbaxy Merger Will Create New Global Generics Major
Industry Trend Analysis - BMS' Daclatasvir Combination For HCV GT3 Will Struggle Despite Positive Phase III Data
Industry Brief - FDA Cancels Advisory Committee Meeting On Merck's Sugammadex; CRL Expected
Industry Brief - Actavis See Success In German Pemetrexed Patent Challenge
Industry Trend Analysis - Targeted Oncology Medicine Continues To Drive Spending
Industry Brief - Encruse Ellipta Approved In Japan For COPD
Industry Brief - First-In-Class Type II Diabetes Treatment Glyxambi Available In US Pharmacies
Industry Brief - Breo Ellipta Gets Mixed FDA Panel View For Asthma Indication
Industry Brief - FDA Approves Saphris As MT For Paediatric Patients With Bipolar I Disorder
Industry Brief - NHS Delists Sanofi's Jevtana/Zaltrap From CDF
Industry Trend Analysis - EC Approval For PV Pushes Jakavi Closer To Blockbuster Status
Industry Brief - Saxenda Approved In Europe For Obesity
Industry Brief - NICE Recommends Stelara For Active PsA
Industry Brief - Amgen Astellas BioPharma Seeks Japanese Approval For Evolocumab
Industry Brief - Consilient Launches Pregabalin Capsules In UK
Industry Brief - Eisai's Lenvima Approved In Japan For Unresectable TC
Industry Trend Analysis - BMS/Merck Still Battling For Melanoma Market Share
Industry Trend Analysis - Dementia Research To See Increased Investment
Industry Brief - Positive Results From AstraZeneca's PT003 COPD Programme
Industry Trend Analysis - Imbruvica Will Allow AbbVie To Recoup After Costly Pharmacyclics Deal
Industry Brief - Opicapone Significantly Improves Off Time In Fluctuating PD Patients As Add-On To Levodopa
Industry Brief - Amgen's Repatha In Combination With Statins Reduced LDL-C In High-Risk Japanese Patients
Industry Trend Analysis - Failing Phase II Trial Will Not Deter ASONEP's Development

Table Of Contents

Key Pharma News 30 MARCH 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.